Sign in
NVIVQ Stock Price, Chart, Stats & News
InVivo Therapeutics Holdings Corporation
Save
InVivo Therapeutics Holdings Corporation (NVIVQ) does not currently pay a dividend.
1.15M
Market cap
–
Current P/E
–
Forward P/E
NVIVQ chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
InVivo Therapeutics Holdings Corp. is a U. S.-based biotechnology and biomaterials company, engaged in both research and clinical development. The company's primary focus is on pioneering and commercializing biopolymer scaffolding devices specifically designed for the treatment of spinal cord injuries (SCI).
Similar securities
Based on sector and market capitalization
Report issue